Last reviewed: June 22, 2026 Last updated: June 22, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
About 10%-25% of patients with NAFLD will develop non-alcoholic steatohepatitis (NASH), which increases the risk of liver cirrhosis or liver cancer (185)
Global histone modification patterns predict risk of prostate cancer recurrence
Used wisely, it can help you recover faster, train harder, and avoid the long-term breakdown that sidelines so many athletes
Dose strengths: Wegovy injection comes in five dose strengths : 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg